Archives: Speakers

Andreia Cruz e Silva is passionate about working with patient data and looking for innovative ways to improve the field of Data Management in Clinical Research. Has gained experience on Sponsor-CRO interaction as a Clinical Data Manager and Data Analyst at the German midsize pharmaceutical company medac GmbH. With a strong background in scientific research and medical sciences, Andreia completed a Masters in neuroscience (University of Lisbon) and a PhD in biochemistry (Free University of Berlin).

I studied Medicine in Universidad de Navarra (Spain) and did my especialization in oncologist in the same site between 1997 and 2001. I have work as medical oncologist during several years in Pamplona and Madrid, and I joined Roche in 2007 as Country Study Manager. My current position is Therapeutic Area Leader in Clinical Operations for Onco-Hematology studies from 2015. I have a master in coaching and talent development and another in pharmaeconomics and health economy.

CEO of a clinical trials unit that was founded from scratch in 2017 at a state hospital in Ivano-Frankivsk, Ukraine and now developed into an organization with 15-20 multi-specialty trials running simultaneously with a potential to grow. One of the founders and current Board member of the Ukrainian Association for Clinical Research. Adept ENT doctor and principal investigator in otolaryngology with ability to work in a multidisciplinary team, experience in delivering patient care in both public and private settings with the use of the latest industry equipment and technology, as well as establishing own private practice. Proactive and dedicated to seeking opportunities for cooperation with international specialists. Strong knowledge of Ukrainian medical policy landscape through working with the Ministry of Health of Ukraine on reforming healthcare services. Proven track record of planning and executing projects in medical sphere.

Disa has 15+ years of experience working in technology and innovation especially in the pharmaceutical industry. She is the Head of Integrated Clinical and Operational Analytics at Janssen Pharmaceutical Companies part of Johnson & Johnson. She was previously at UCB as the Head of Innovation and held other leadership roles. Prior to joining the pharma, she was a co-founder of an IT company. She has an EMBA and B.S. in Pharmaceutical Chemistry. In 2017, Disa started a consortium, a cross-industry collaboration on blockchain via PhUSE. Recently, she was awarded Top 100 Women in Technology, Financial Times top 100 most influential BAME Leader, and featured on the cover of CIO Look celebrating Women in Tech 2019. Her passion is on closing the gap for patients with unmet needs and exploring the right digital technologies to accelerate the implementation of end-to-end patient solution.

Nina Levin is a senior communications professional with extensive client-facing experience and a thorough understanding of corporate communications and internal and compliance processes. In her role as vice president of client success at Within3, she directs and identifies activities to meet KPIs by developing tailored strategic plans and drawing on experience across medical communications, advertising, and PR to set clients up for success. Nina’s proven track record and industry expertise allows her to deliver and oversee client support activities and apply her experience in process development, improvement, and implementation to ensure optimal results while meeting timelines and providing cost-effective deliverables.

Guillem is the Founder and CEO of MediQuo as well as the Founder of MeetingDoctors. Investor and board member of more than 30 startups including: Singularu, Cuidum, Landbot, Demium, Homyspace, Hannun, Taiga Agile, Swipcar, Catevering, Dental Residency, Brickbro, Twenix, The Wild Curl, Shimoku, Spathios, Trialing, Pulpo, Rebag, Impossible Bakers, Incapto and Buscoresi among others. He is a physician and mathematician with an MBA from IESE Business School and has deep knowledge in the eHealth market, MedTech and early seed startups. Guillem’s technical knowledge includes the areas of data-mining, signal processing, artificial intelligence and product development.

Alastair has 30+ years of experience in the biopharmaceutical development of pre- and post-approval drugs, joining Syneos Health on 2017. Prior to joining Syneos Health, Alastair had a Global Delivery Head role at AstraZeneca with responsibility for the delivery of both pre and post approval programmes supporting key brands

As a Director, Operational Strategy with over 17 years’ experience from the Pharma, Biotech and CRO side of clinical trial planning, execution and leadership, Alexis uses her expertise to support Precision for Medicine (PFM) clients. This includes the development of study and portfolio level strategies. Alexis has managed global studies from Phase I FIH to logistically complex Phase III studies and has a passion for operational excellence, process management and study finance. Alexis holds a degree in Neuroscience and a Masters in Biotechnology Law and Ethics. With a focus in Oncology and Rare Disease, PFM is now also supporting clients within Neurology, CVS and Pediatric indications.

Owen Corbin is an attorney admitted to the NC Bar (1996), CIPM, with more than 15 years of industry experience helping customers navigate a complex global regulatory landscape. He joined IQVIA in 2012 and is currently Sr. Director, DCT Regulatory and Privacy for IQVIA Decentralized Clinical Trials.

Dr. Bhargava Reddy has over 16 years of experience working in the pharmaceutical industry. He is currently Head of Advanced Insights at Janssen Pharmaceutical supporting clinical operations by providing data science solutions. Prior to this role, he was Associate Director of Advanced Analytics at UCB. In this role, he was responsible for the development and application of machine learning methodologies supporting clinical decision making within Immunology and. He was also leading the analytics work supporting Risk Based Monitoring. Prior to this role, he managed a statistical programming group and was also overseeing a large statistical programming group offshore. Dr. Reddy has published several methodology papers in peer reviewed academic journals in the areas of machine learning and deep learning. He is actively involved as an associate editor for the Frontiers in AI journal and also as a reviewer on several journals. He has a Ph.D. from Oklahoma State University and MS from Northwestern University.